Viewing StudyNCT00025727



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00025727
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2001-10-15

Brief Title: Comparison of Two Dosing Regimens of GW433908Ritonavir Versus LopinavirRitonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Sponsor: GlaxoSmithKline
Organization: NIH AIDS Clinical Trials Information Service

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
VX-175 View
HIV-1 View
HIV Protease Inhibitors View
Ritonavir View
RNA Viral View
Anti-HIV Agents View
Viral Load View
ABT 378 View